BM
BMWKY
Bayerische Motoren Werke AG$21.05 −0.33 (−1.54%)
Oct 27 4:00 PM ET · prev $21.38
Median target
🔒 Subscribers only
1 year
−33.1%
from $31.46 · Oct 28
30 days
+0.5%
from $20.95
52-week range
$19.54–37.65
−44% from high · low Oct 8
Avg volume 20D
338.5K
shares / day
Short interest
30.0K
−31.2%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- E Jun 8 Trial readout: Results Pending: Oxymetazoline HCl 0.05% nasal gel (Phase…
- X Aug 14 Short interest jumps 52.9% to 50.5K
- X Aug 31 Short interest jumps 43.2% to 72.3K
- X Sep 15 Short interest jumps 66.5% to 120.3K
- X Sep 30 Short interest falls 63.7% to 43.7K
- X Oct 15 Short interest falls 31.2% to 30.0K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- Short sellersCOVERING
Short interest −31.2% to 30.0K shares. 1.0 days to cover.
- TrendDOWNTREND
5% below its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| RHUMBLINE ADVISERS | ADD | $365.3K |
| RHUMBLINE ADVISERS | DOUBLED | $425.3K |
| RHUMBLINE ADVISERS | DOUBLED | $142.9K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
RHUMBLINE ADVISERS — ADD
16,798 shares ($365.3K)
Jun 8, 2026 Clinical trial readout
Results Pending: Oxymetazoline HCl 0.05% nasal gel (Phase 2) — Completed 11d ago
Trial: A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It
Jun 1, 2026 Event
Adempas
WARNING: EMBRYO-FETAL TOXICITY Do not administer Adempas to a pregnant female because it may cause f
Dec 31, 2025 Inst.
RHUMBLINE ADVISERS — DOUBLED
11,687 shares ($425.3K)
Short side
FINRA· Oct 15, 202630,029
shares short
-31.2%
vs prior settlement
1.0
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jun 8, 2026
Trial readout
Results Pending: Oxymetazoline HCl 0.05% nasal gel (Phase 2) — Completed 11d ago
Trial: A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults Sponsor: Bayer Phase: Phase…
Jun 1, 2026
FDA
Adempas
WARNING: EMBRYO-FETAL TOXICITY Do not administer Adempas to a pregnant female because it may cause fetal harm [see Contraindications ( 4.1 ), Warnings
May 14, 2026
Short interest
FTD: BMWKY — 34,499 shares ($1.1M) failed to deliver
Settlement: 20260514, Price: $31.81, FTD Value: $1,097,413.19, BAYERISCHE MOTOREN WERKE A G A
May 8, 2026
Short interest
FTD: BMWKY — 36,265 shares ($1.2M) failed to deliver
Settlement: 20260508, Price: $32.63, FTD Value: $1,183,326.95, BAYERISCHE MOTOREN WERKE A G A
Mar 31, 2026
Short interest
FTD: BMWKY — 26,195 shares ($0.8M) failed to deliver
Settlement: 20260331, Price: $29.58, FTD Value: $774,848.1, BAYERISCHE MOTOREN WERKE A G A